Merck Cited in Growing Single-Use Bioprocessing Market

Reports today highlight Merck & Co., Inc.'s position within the rapidly expanding global market for single-use assemblies. This segment of the bioprocessing industry is forecast to experience substantial growth, with a projected compound annual growth rate of 22.8% through 2030. Key industry players, including Merck, Thermo Fisher, Danaher, Sartorius, and Avantor, are reportedly scaling their modular bioprocessing capabilities to capitalize on this trend.

The expansion in single-use technologies is crucial for modern biopharmaceutical manufacturing, offering flexibility and efficiency in drug production. The increasing demand for these assemblies underscores the evolving landscape of healthcare and pharmaceutical development, with companies investing in technologies that can streamline production and reduce contamination risks.

This development occurs against a backdrop of mixed signals in the broader healthcare sector. Coverage today notes potential strains within the medtech industry, as evidenced by recent market movements concerning major companies like Johnson & Johnson. Some analysis suggests that the pharmaceutical segment may be playing a vital role in sustaining the overall performance of healthcare stocks during periods of market recalibration.